{"abortion spontaneous": 11.6, "acne": 2.85, "application site burn": 55.2, "application site discolouration": 219.86, "application site erythema": 38.95, "application site hypersensitivity": 229.86, "application site irritation": 103.21, "application site pain": 3.58, "application site pruritus": 122.39, "application site rash": 178.27, "application site reaction": 28.76, "application site vesicles": 36.15, "breast pain": 5.4, "deep vein thrombosis": 6.22, "depression": 2.33, "dermatitis contact": 30.45, "ectopic pregnancy": 44.82, "exposure during pregnancy": 140.25, "fluid retention": 2.5, "haemorrhage": 2.67, "inappropriate schedule of product administration": 6.35, "intermenstrual bleeding": 8.86, "maternal exposure during pregnancy": 4.57, "medication error": 9.95, "mood swings": 3.36, "pregnancy": 16.1, "pregnancy with contraceptive patch": 135097.14, "product adhesion issue": 423.69, "product administered at inappropriate site": 49.16, "product administration error": 5.08, "product complaint": 94.13, "product dose omission issue": 2.49, "product quality issue": 3.69, "product use in unapproved indication": 3.07, "pulmonary embolism": 7.83, "skin irritation": 19.46, "skin reaction": 3.88, "therapeutic response decreased": 9.02, "therapeutic response unexpected": 3.38, "thrombosis": 2.75, "underdose": 6.99, "unintended pregnancy": 757.64, "unwanted pregnancy": 1800.26, "vaginal haemorrhage": 18.97, "weight increased": 2.09, "wrong technique in product usage process": 15.66}